This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Ensign Group Shares Are Attracting Investors Now
by Zacks Equity Research
ENSG stock is surging on revenue growth, acquisitions and raised 2025 earnings and sales guidance.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Ensign Group, Inc. (ENSG) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Ensign Group (ENSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why Ensign Group (ENSG) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 Reasons Why Ensign Group (ENSG) Is a Great Growth Stock
by Zacks Equity Research
Ensign Group (ENSG) could produce exceptional returns because of its solid growth attributes.
What Makes Ensign Group (ENSG) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Ensign Group (ENSG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Ensign Group (ENSG) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 Reasons Why Growth Investors Shouldn't Overlook Ensign Group (ENSG)
by Zacks Equity Research
Ensign Group (ENSG) could produce exceptional returns because of its solid growth attributes.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Ensign Group, Inc. (ENSG) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Ensign Group (ENSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cigna Q2 Earnings Beat Estimates on Higher Specialty Volumes
by Zacks Equity Research
CI's Q2 earnings benefit from strong Evernorth Health Services unit, offsetting customer losses and rising costs. It continues to expect 2025 adjusted EPS at a minimum of $29.60.
HUM Misses Q2 Earnings on Higher Benefit Costs, Ups '25 EPS View
by Zacks Equity Research
Humana's Q2 earnings fall year over year on a declining membership base. Notably, 2025 adjusted EPS is currently forecasted at around $17.00, up from the earlier view of around $16.25.
ENSG's Q2 Earnings Beat on Higher Occupancy Rates, Stock Up 9%
by Zacks Equity Research
Ensign Group's Q2 earnings improve 20.5% year over year, fueled by stronger occupancy, patient days and rental revenues.
Ensign Group (ENSG) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of +3.25% and +1.77%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Ensign Group (ENSG) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Ensign Group Boosts U.S. Presence With Idaho and Texas Facility Buyouts
by Zacks Equity Research
ENSG adds Idaho and Texas facilities to its skilled nursing facility and real estate portfolios and earns an opportunity to boost revenues by catering to growing patient volumes.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is The Ensign Group (ENSG) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Ensign Group (ENSG) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Why Ensign Group (ENSG) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why ENSG Shares Are Attracting Prudent Investors Now
by Zacks Equity Research
The Ensign Group's 23.8% stock gain, strong earnings outlook and low debt levels are drawing investor attention despite rising costs.
Buy These 5 Low-Leverage Stocks Amid Fresh Iran-Israel War
by Aparajita Dutta
As markets reel under the Israel-Iran conflict, NVS, ENSG, MTZ, BILI and STRL stocks offer a safer path through volatility.
Here's Why Ensign Group (ENSG) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Ensign Enhances Presence With 3 New Acquisitions in 2 States
by Zacks Equity Research
ENSG adds three skilled nursing facilities in Idaho and California, boosting its U.S. footprint and fueling future growth.